Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted imidazo[1,2-a]pyrazines as soluble guanylate cyclase activators

Substituted imidazo[1,2-a]pyrazines as soluble guanylate cyclase activators

US Patent 10245264 · Granted Apr 2, 2019

Estimated economic value: $187,389,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted pyrazolo[3,4-d]pyrimidines as PDE9 inhibitors2021
Substituted pyrazolo[3,4-d]pyrimidines as PDE9 inhibitors2021
Methods for using triazolo-pyrazinyl soluble guanylate cyclase activators in fib2021
Fused pyrazine derivatives useful as soluble guanylate cyclase stimulators2020
Fused pyrazine derivatives useful as soluble guanylate cyclase stimulators2020
Fused pyrazine derivatives useful as soluble guanylate cyclase stimulators2020
Spirocyclic Pyridotriazine Derivatives useful as HIV integrase inhibitors2020
Amido-substituted pyridotriazine derivatives useful as HIV integrase inhibitors2020
Tricyclic compounds as inhibitors of mutant IDH enzymes2019
Factor XIa inhibitors2019
Tricyclic compounds as inhibitors of mutant IDH enzymes2019
Soluble guanylate cyclase stimulators2019